Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
American Cancer Society
Apr 27, 2024, 14:14 |
Blog
Registration is open for NANETS. Regional NET Education Program in Providence - Yale Cancer Center
Pamela Kunz shared a post by Yale Cancer Center, on X: "Please join us for this great…
Apr 27, 2024, 11:36 |
Drugs
ASCO's Open Letter to Congress and the Administration To End Cancer Drug Shortages
The American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "Did you know…
Apr 27, 2024, 10:35 |
Blog
Maite Bourlon: High-risk locally advanced Prostate cancer - Neha Vapiwala, Silke Gillessen
Maite Bourlon shared on X/Twitter: "Advanced Prostate Cancer Consensus Conference 2024 Consesnsus! High-risk locally advanced Prostate…
Apr 27, 2024, 08:27 |
Societies
American Radium Society Appropriate Use Criteria Thoracic Committee provided guidance on the management of unresectable locally advanced NSCLC - MSK Radiation Oncology
Memorial Sloan Kettering Radiation Oncology shared on X: “Evidence-based guidance on the management of unresectable…
Apr 27, 2024, 07:08 |
Blog
Oncologist Near Me - Eric Small: Prominent Prostate Cancer Specialist
Oncologist Near Me: Eric Small Special initiative by OncoDaily Welcome to OncoDaily's special section "Oncologist…
Apr 26, 2024, 17:44 |
Drugs
Paolo Tarantino: The agnostic potential of Antibody Drug Conjugates with Roberto Carmagnani Pestana, MD is among the most cited of 2022-2023 on CA - A Cancer Journal for Clinicians
Apr 26, 2024, 16:34 |
Dialogues
Oncothon: ASCO And Cancer Drug Development
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 26, 2024, 08:37 |
Blog
Karen Knudsen: A huge thank you to the 74 CEOs who participated in our one-day Fit2BeCancerFree CEO Challenge
Karen Knudsen shared on X/Twitter: ''A huge thank you to the 74 CEOs who participated in…
Apr 25, 2024, 21:09 |
Insight
Piotr Wysocki: Salvage re-irradiation is a feasible option in locally recurrent prostate cancer after primary curative radiotherapy
Piotr Wysocki recently shared on LinkedIn: "Locally recurrent prostate cancer (PC) in patients who underwent primary…
Apr 25, 2024, 21:06 |
Drugs
Piotr Wysocki: Datopotamab deruxtecan – another anti-TROP2 conjugate demonstrating activity in advanced ER+/HER2- and triple-negative breast cancer patients
Piotr Wysocki recently shared on LinkedIn: "Datopotamab deruxtecan – a novel anti-TROP2 conjugate demonstrates activity…
51
52
53
54
55
All:
1863
Posts:
521 - 530
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube